publication date: May. 8, 2015

Duke Settles with Potti’s Patients; Misconduct Probe Now in Fifth Year


Duke University has settled the suits filed by patients who were enrolled in clinical trials that were testing the technology developed by Anil Potti and his mentor Joseph Nevins.

By settling, Duke avoided having to confront embarrassing revelations about how much the university’s deans knew about the problems in the genomic research organization.

“All claims arising out of the genomics-based clinical trials for cancer treatment have been resolved and settled. The specific terms of the settlement are confidential, by mutual agreement of the parties,” Duke officials said in a statement about the settlement which was first acknowledged last Friday. “There are no other pending claims or lawsuits.”

Thomas Henson, an attorney for the plaintiffs, confirmed Duke’s statement, offering no additional information.

The case was the subject of a report on the CBS news program 60 Minutes.

“The trial is one of the two shoes I was waiting to drop,” said Keith Baggerly, a biostatistician at MD Anderson Cancer Center, whose challenge of the papers published by the Duke genomics team uncovered the irregularities. “Misconduct investigation is the other.”

Baggerly served as an expert witness for the plaintiffs.

“Bottom line: the settlements do not resolve Duke’s responsibilities for the multiple individual and systemic failures evident in this situation,” said C. K. Gunsalus, director of the National Center for Professional and Research Ethics. “Duke owes information … Continue reading 41-18 Duke Settles with Potti’s Patients; Misconduct Probe Now in Fifth Year

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.